文献速递主动脉疾病外周动脉疾病内脏/肾动脉与血管畸形

Gore杂交血管移植物在复杂血运重建中的临床经验显示安全有效

Clinical Experience with the Gore Hybrid Vascular Graft in Complex Revascularizations Demonstrates Safety and Efficacy.
PubMed 文献 · Ann Vasc Surg · 2019-12-20

单中心回顾性分析43例患者共56枚Gore杂交血管移植物用于复杂血运重建,18个月一期、辅助一期和二期通畅率分别为82%、86%和96%。移植物多置于髂外动脉(27/56)和肾动脉(12/56),早期死亡与疾病本身相关而非手术干预。

要点

  • GHVG在复杂血运重建中18个月二期通畅率达96%。
  • 髂外动脉和肾动脉是主要置入部位。
  • 早期死亡与疾病性质相关,非手术干预所致。

核心结论

  • GHVG可在条件不佳的血管中实现无缝线吻合,避免内脏分支长时间缺血或避免广泛腹壁/腹膜后暴露。

研究设计与样本

  • 单中心回顾性系列,2012年3月至2017年4月Houston Methodist Hospital共43例患者置入56枚GHVG。
  • 排除随访丢失5例(7枚移植物)及移植物无关死亡8例(11枚移植物)。

主要发现

  • 18个月一期通畅率82%、辅助一期通畅率86%、二期通畅率96%。
  • 移植物置入部位:髂外动脉27/56、肾动脉12/56、股总动脉6/56、股浅动脉4/56、髂总动脉3/56、移植物3/56、股深动脉1/56、肠系膜上动脉1/56。
  • 早期死亡7/8例与疾病性质相关,非手术干预所致。

临床怎么用

  • 对于不适合传统开放手术旁路的复杂血运重建,GHVG可作为一种选择。

局限性

  • 回顾性单中心设计,证据级别IV级。
  • 排除随访丢失及移植物无关死亡患者,可能影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arterial revascularizations can present significant challenges when vessels are disadvantaged and advances in technology present the surgeon with innovative opportunities. A number of studies have used the GORE® Hybrid Vascular Graft (GHVG), and we have been using this device in arterial revascularizations since it came to market. The aim of this study is therefore to present a large single-center experience using the GHVG. This series presents patients with complex revascularizations in multiple vascular beds. METHODS: We retrospectively analyzed a single-center series of 43 patients who received a total of 56 GHVGs in complex revascularization procedures at Houston Methodist Hospital from March 2012 to April 2017. We excluded 5 patients (7 grafts in total) because of loss of follow-up. An additional 8 patients were excluded from the analysis (11 grafts in total) secondary to mortalities unrelated to their grafts (7 patients died during index hospitalization and 1 patient died shortly after discharge). RESULTS: Our results demonstrated an 18-month primary patency, assisted primary patency, and secondary patency of 82, 86, and 96%, respectively. These complex revascularizations included a total of 56 devices placed. GHVGs were placed in the external iliac artery (27/56), renal artery (12/56), common femoral artery (6/56), superficial femoral artery (4/56), common iliac artery (3/56), grafts (3/56), profunda femoris artery (1/56), and the superior mesenteric artery (1/56). Early mortality in patients (7/8) was because of the nature of their disease and not related to the surgical intervention. CONCLUSIONS: The GHVG has the ability to create a sutureless anastomosis in a disadvantaged vessel or to promote a potentially better outcome by either avoiding prolonged ischemia to visceral branches or avoiding extensive abdominal or retroperitoneal exposure in an iliofemoral bypass. These results demonstrate the value of the GHVG in complex revascularizations not amenable to traditional open surgical bypass. LEVEL OF EVIDENCE: IV.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nguyen-Lee JJ, Zubair MM, Chegireddy V, et al. Clinical Experience with the Gore Hybrid Vascular Graft in Complex Revascularizations Demonstrates Safety and Efficacy. Ann Vasc Surg. 2019. PMID: 31870790. doi:10.1016/j.avsg.2019.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。